Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.
The LentiPeak™ platform can accelerate development and commercialization, using GMP manufacturing, scale-down model validation, and a process design approach.
Specialized external expertise can complement your in-house team to swiftly tackle complex issues, minimize downtime, and maintain productivity in a technologically advanced environment.
Specially designed for pharmaceutical products, with the robot-assisted labeling cell 211R HC, solve challenges in wrap-around labeling of label material more effectively.
The streamlined AAV transient transfection platform de-risks your path to IND and reduces complexity and timeline for lengthy process and analytical development.
Uncover the importance of accessing expertise that can help nascent novel therapies make the leap from the bench to the clinic and, eventually, to the market in a shifting landscape.
As a CDMO Partner for Life™, our goal is to advance your cell therapies from lab to commercial scale, leveraging our cell and gene therapy expertise and global cGMP network.
Excellos is offering a limited number of complimentary 60-minute CMC consultations designed to provide early-stage developers with strategic guidance before they engage a CDMO partner.
Whether you are just beginning your development or are advancing toward commercialization, we provide the global laboratory infrastructure necessary for success.
Explore insights into an AAV manufacturing platform designed to achieve short timelines and cost-effective scalability for producing clinical trial and commercial material in bioreactors up to 2000 L.
